Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Parthenon LLC

Parthenon LLC decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,648 shares of the pharmacy operator’s stock after selling 1,847 shares during the quarter. Parthenon LLC’s holdings in Walgreens Boots Alliance were worth $501,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Walgreens Boots Alliance by 2.0% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 67,016 shares of the pharmacy operator’s stock worth $600,000 after buying an additional 1,326 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 4.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 1,063 shares in the last quarter. Eastern Bank acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth $33,000. Elevated Capital Advisors LLC raised its position in shares of Walgreens Boots Alliance by 35.5% during the third quarter. Elevated Capital Advisors LLC now owns 53,605 shares of the pharmacy operator’s stock worth $480,000 after purchasing an additional 14,043 shares during the period. Finally, International Assets Investment Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 701.3% during the third quarter. International Assets Investment Management LLC now owns 282,619 shares of the pharmacy operator’s stock valued at $2,532,000 after purchasing an additional 247,350 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

WBA has been the topic of several recent analyst reports. Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Jefferies Financial Group decreased their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Finally, Royal Bank of Canada upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $13.19.

Walgreens Boots Alliance Trading Down 2.4 %

NASDAQ:WBA opened at $10.79 on Thursday. The stock’s 50 day moving average price is $10.36 and its 200 day moving average price is $9.71. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the prior year, the business posted $0.66 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.